...women is cerebral venous sinus thrombosis (CVST), which was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred in women between the ages of 18...
On September 19th, the National Council on Compensation Insurance (NCCI) hosted a webinar reviewing opioid prescribing patterns and the likelihood of continued opioid use among injured workers. Data presented came...
In late August, the FDA officially approved the Pfizer-BioNTech COVID-19 vaccine, which will officially be marketed as Comirnaty. This is the first FDA-approved vaccine for the prevention of COVID-19 and...
Leiters Health is voluntarily recalling 33 lots of IV vancomycin, phenylephrine, and fentanyl products at the user level due to superpotency because the bags may contain twice the labeled amount...
Wisconsin Assembly Bill 651 was introduced, which proposes several different changes to existing workers’ comp law. Currently, there is a statute of limitations for bringing claims to worker’s comp. For...
Back in September, Sandoz Inc. voluntarily recalled all quantities and lots within expiry of ranitidine hydrochloride capsules because of confirmed contamination with N-Nitrosodimethylamine (NDMA), a probable human carcinogen, above levels established by...
Teva Pharmaceuticals has voluntarily recalled specific lots of various strengths of fentanyl buccal tablets CII at the consumer level due to a labeling error. This recall has been initiated because...
...384 to 542, approximately 40%. Historically, research institutions have faced much difficulty completing the intensive, time-consuming application process to study marijuana that required cooperation with the DEA, the National Institute on Drug...
A new, non-opioid pain medication from Vertex Pharmaceuticals demonstrated positive results in Phase 2 proof of concept trials, showing promise for other potential indications in pain management. VX-548 was tested...
...13 GLP-1 RAs are FDA approved, with more currently in research and development. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp, visit Med Monitor online....
...and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee. The meeting discussed two recently completed observational studies examining the risks of misuse, abuse, addiction, and...
...in Workers' Compensation Stay Informed Healthesystems will keep you current on what’s happening in workers’ comp with: Workers’ Comprehensive Our e-newsletter covers the latest clinical developments, policy changes, industry events,...
...one or more of these medications. The drug classes with the greatest number of new, high-priced drugs were anti-cancer drugs, ADHD/anti-obesity drugs, and anti-inflammatory pain relief medications. For each of...
...They are committed to providing us with the right information at the right time so we can make well educated and informed decisions about workers’ compensation patients.” - Client Partner...
The California Division of Workers’ Compensation (DWC) is proposing updates to the Medical Treatment Utilization Schedule (MTUS) for mental health injuries. The changes would adopt the latest Workplace Mental Health...
